Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mathematical Model of Intrinsic Drug Resistance in Lung Cancer.

International journal of molecular sciences - 31 Oct 2023

Kozłowska Emilia, Swierniak Andrzej

Abstract excerpt

Drug resistance is a bottleneck in cancer treatment. Commonly, a molecular treatment for cancer leads to the emergence of drug resistance in the long term. Thus, some drugs, despite their initial excellent response, are withdrawn from the market. Lung cancer is one of the most mutated cancers, leading to dozens of targeted therapeutics available against it. Here, we have developed a mechanistic mathematical model...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Computer Simulation
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Models, Theoretical

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 37958784
DOI: 10.3390/ijms242115801
PMCID: PMC10650033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mathematical Model of Intrinsic Drug Resistance in Lung Cancer.PMID 37958784Read ↗

Pathological transition as the arising mechanism for drug resistance in lung cancerSemantic proximity Read ↗

Computational Methods for the Analysis and Prediction of EGFR-Mutated Lung Cancer Drug Resistance: Recent Advances in Drug Design, Challenges and Future Prospects.Semantic proximity Read ↗

Drug Resistance and Its Significance for Treatment Decisions in Non-Small-Cell Lung CancerSemantic proximity Read ↗

Longitudinal single-cell RNA model aids prediction of EGFR-TKI resistance.Semantic proximity Read ↗

Drug resistance in cancer mechanisms and modelsSemantic proximity Read ↗

Drug resistance in lung cancerSemantic proximity Read ↗

Mathematical Approach to Differentiate Spontaneous and Induced Evolution to Drug Resistance During Cancer TreatmentSemantic proximity Read ↗

Mechanistic insights into acquired drug resistance in epidermal growth factor receptor mutation-targeted lung cancer therapy.Semantic proximity Read ↗

Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib.Semantic proximity Read ↗

Computational platform for modelling, analysis, and prediction of anti-EGFR drug resistance for lung cancer.Semantic proximity Read ↗

Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures.Semantic proximity Read ↗

In vitro model for resistance in oncogene-dependent tumors at the limit of radiological detectabilitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.